
A new collaboration deal is going to enable Danish biotech projects to team up with US counterparts in order to optimize their work, says Morten Mølgaard Jensen, CEO of the Copenhagen Bio Science Park (COBIS), who recently headed to Boston to discuss the Danish/US collaboration.
According to the CEO, the prospects of the deal panning out are great.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app